Parametrica Management LTD Biomarin Pharmaceutical Inc Transaction History

Parametrica Management LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 22, 2022	SELL	$71.48 - $86.85 $393,568 - $478,196	-5,506 Closed	0 $0
Q1 2022 May 10, 2022	BUY	$74.28 - $92.69 $408,985 - $510,351	5,506 New	5,506 $425,000
Q4 2020 Feb 16, 2021	SELL	$72.61 - $90.2 $522,501 - $649,079	-7,196 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$71.87 - $131.03 $517,176 - $942,891	7,196 New	7,196 $547,000

637

177M

2.01M

1.28M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.4B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Parametrica Management LTD, based on Form 13F filings with the SEC.

Stay updated on Parametrica Management LTD with notifications on news.